332 related articles for article (PubMed ID: 33797702)
1. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
Fu H; Chu D; Geng X
Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
[TBL] [Abstract][Full Text] [Related]
2. BMP-7 inhibits renal fibrosis in diabetic nephropathy via miR-21 downregulation.
Liu L; Wang Y; Yan R; Liang L; Zhou X; Liu H; Zhang X; Mao Y; Peng W; Xiao Y; Zhang F; Liu L; Shi M; Guo B
Life Sci; 2019 Dec; 238():116957. PubMed ID: 31655195
[TBL] [Abstract][Full Text] [Related]
3. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
4. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway.
Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484
[TBL] [Abstract][Full Text] [Related]
5. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
[TBL] [Abstract][Full Text] [Related]
6. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
7. MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy.
Wang HJ; Liu H; Lin YH; Zhang SJ
Hum Exp Toxicol; 2021 Apr; 40(4):587-595. PubMed ID: 32959695
[TBL] [Abstract][Full Text] [Related]
8. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
[TBL] [Abstract][Full Text] [Related]
9. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
[TBL] [Abstract][Full Text] [Related]
10. MiR-130b increases fibrosis of HMC cells by regulating the TGF-β1 pathway in diabetic nephropathy.
Ma Y; Shi J; Wang F; Li S; Wang J; Zhu C; Li L; Lu H; Li C; Yan J; Zhang X; Jiang H
J Cell Biochem; 2019 Mar; 120(3):4044-4056. PubMed ID: 30260005
[TBL] [Abstract][Full Text] [Related]
11. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B
Nephron; 2022; 146(1):110-120. PubMed ID: 34724669
[TBL] [Abstract][Full Text] [Related]
12. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.
Li X; Zeng X
Cell Biol Int; 2020 Feb; 44(2):467-476. PubMed ID: 31617643
[TBL] [Abstract][Full Text] [Related]
13. Xiaokeping mixture inhibits diabetic nephropathy in streptozotocin-induced rats through blocking TGF-β1/Smad7 signaling.
Xin C; Xia Z; Jiang C; Lin M; Li G
Drug Des Devel Ther; 2015; 9():6269-74. PubMed ID: 26664048
[TBL] [Abstract][Full Text] [Related]
14. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.
Zhong X; Chung AC; Chen HY; Dong Y; Meng XM; Li R; Yang W; Hou FF; Lan HY
Diabetologia; 2013 Mar; 56(3):663-74. PubMed ID: 23292313
[TBL] [Abstract][Full Text] [Related]
15. Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs.
Chung AC; Dong Y; Yang W; Zhong X; Li R; Lan HY
Mol Ther; 2013 Feb; 21(2):388-98. PubMed ID: 23207693
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1.
Hu W; Han Q; Zhao L; Wang L
J Cell Physiol; 2019 Feb; 234(2):1469-1476. PubMed ID: 30054916
[TBL] [Abstract][Full Text] [Related]
17. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Li Z; Hong Z; Peng Z; Zhao Y; Shao R
Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
[TBL] [Abstract][Full Text] [Related]
18. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
19. A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells.
Kato M; Arce L; Wang M; Putta S; Lanting L; Natarajan R
Kidney Int; 2011 Aug; 80(4):358-68. PubMed ID: 21389977
[TBL] [Abstract][Full Text] [Related]
20. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
